Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,3 Dimethyl 2 imidazolidinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1067058C details a continuous addition method for producing >99.9% purity DMI, eliminating imine by-products for electronic and polymer applications.